Cita APA (7a ed.)
Yoshiura, H., Kawata, Y., & Sengoku, S. (2025). Open Innovation and Regulatory Challenges in New Modality Development: The Pivotal Role of Contract Development and Manufacturing Organisations in Advancing Antibody Drugs. Therapeutic Innovation & Regulatory Science, 59(1), 63-71.
Cita Chicago Style (17a ed.)
Yoshiura, Hiromu, Yayoi Kawata, y Shintaro Sengoku. "Open Innovation and Regulatory Challenges in New Modality Development: The Pivotal Role of Contract Development and Manufacturing Organisations in Advancing Antibody Drugs." Therapeutic Innovation & Regulatory Science 59, no. 1 (2025): 63-71.
Cita MLA (9a ed.)
Yoshiura, Hiromu, et al. "Open Innovation and Regulatory Challenges in New Modality Development: The Pivotal Role of Contract Development and Manufacturing Organisations in Advancing Antibody Drugs." Therapeutic Innovation & Regulatory Science, vol. 59, no. 1, 2025, pp. 63-71.
Precaución: Estas citas no son 100% exactas.